[Controlled study of a new anti-allergic agent, N-acetyl-aspartyl- glutamic acid (NAAGA), in the local treatment of pollinosis].
Girard
J P
JP
Weibel
M A
MA
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004151:Dipeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011058:Pollen; D011897:Random Allocation; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D004151:Dipeptides; C027172:isospaglumic acid
Etude contrôlée d'un nouvel antiallergique, l'acide N-acétyl-aspartyl-glutamique (NAAGA), dans le traitement local de la pollinose.